18757403 |
Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation
Pollock, PM,
Wellens, CL,
Goodfellow, PJ,
Gartside, MG,
Mallon, MA,
Powell, MA,
Byron, SA,
Keenan, JB
|
Cancer Res |
2008 |
17525745 |
Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes
Futreal, PA,
Pollock, PM,
Goodfellow, PJ,
Gartside, MG,
Stratton, MR,
Davies, H,
Mallon, MA,
Mohammadi, M,
Dejeza, LC,
Powell, MA,
Trent, JM
|
Oncogene |
2007 |
17803937 |
A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases
Eliseenkova, AV,
Miller, WT,
Chen, H,
Li, W,
Mohammadi, M,
Xu, C,
Ma, J,
Neubert, TA
|
Mol Cell |
2007 |
18552176 |
Drug-sensitive FGFR2 mutations in endometrial carcinoma
Akslen, LA,
Cibulskis, K,
Greulich, H,
Dutt, A,
Sellers, WR,
Chen, TH,
Winckler, W,
Wyhs, N,
Ziaugra, L,
Zody, MC,
Salvesen, HB,
Meyerson, M,
Stefansson, IM,
Trovik, J,
Wong, KK,
Ramos, AH,
Richter, DJ,
Gabriel, S,
Nicoletti, R,
Onofrio, RC,
Grewal, R,
Hanna, M,
Hatton, C,
Engelsen, IB,
Fennell, T
|
Proc Natl Acad Sci U S A |
2008 |
11781872 |
Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis
Elanko, N,
Rannan-Eliya, S,
Muenke, M,
Tomkins, S,
Reich, EW,
Twigg, SR,
Zackai, EH,
Verloes, A,
McDonald-McGinn, DM,
Wall, SA,
Johnson, D,
Cook, J,
Kan, SH,
Wilkie, AO,
Cornejo-Roldan, L
|
Am J Hum Genet |
2002 |
11055896 |
Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype
Francomano, CA,
Spector, EB,
Bellus, GA,
Garber, AT,
Israel, J,
Bryke, CR,
Speiser, PW,
Donoghue, DJ,
Weaver, CA,
Webster, MK,
Rosengren, SS
|
Am J Hum Genet |
2000 |